CRP and metabolic syndrome: For example, Beumer et al. showed that increases in circulating levels of IL-1β, IL-6 and TNFα are not associated with metabolic syndrome in schizophrenia [30], and Fernandes et al. showed by meta-analysis that CRP is not related to antipsychotic dose in schizophrenia [63].